110. A Phase 3, Multicenter, Double-blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem in Chinese Participants With Complicated Intra-abdominal Infections

BACKGROUND: In China, the prevalence of infections due to multidrug-resistant gram-negative bacteria is high and additional treatment options for complicated intra-abdominal infections (cIAI) are needed. This study compared the efficacy and safety of ceftolozane/tazobactam (C/T) + metronidazole (MTZ...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yihong, Fan, Jia, Chen, Gang, Chen, Xiaofei, Du, Xiaoling, Wang, Ye, Wang, Hui, Sun, Fang, Johnson, Matthew G, Bensaci, Mekki, Huntington, Jennifer A, Bruno, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643727/
http://dx.doi.org/10.1093/ofid/ofab466.110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643727/
http://dx.doi.org/10.1093/ofid/ofab466.110

Ejemplares similares